Virksomhedsform
Anpartsselskab
Etableret
1993
Størrelse
Mellemstore
Ansatte
170
Omsætning
223 MDKK
Bruttofortj.
89 MDKK
Primært resultat (EBIT)
-8.328.000 DKK
Årets resultat
-6.563.000 DKK
Egenkapital
47 MDKK
annonce

Flere nøgletal og analyser?

Med en Bisbase Premium konto får du flere nøgletal for både virksomheder, koncerner og brancher samt adgang til eksklusive brancher indeholdende virksomheder nøje sammensat af eksperter. Og vil du lave dine egne analyser kan du også det! Det tager få minutter at få adgang - og det behøver ikke at koste dig noget!

Rang Årets resultat

Rang i branche
88/89
"Bund 10%"
Rang i Danmark
355.281/360.812
"Bund 10%"

Direktion top 3

Legale ejere top 3

100%Sonova AG

Tegningsregler

Selskabet tegnes af to direktører i forening.

Stamoplysninger baseret på CVR

NavnSonova Audiological Care Denmark Aps
BinavneAudio Consult Slagelse Aps, Audiodan Høreklinik Aps, Audionova Aps, Audionova Hørecenter Aps, Auri Hørecenter Aps, Center for Bedre Hørelse Aps, Den Private Høreklinik Aps, Hørecenter Horsens Aps, Høreteknik, Vejle/Viby Aps, Næstved Hørecenter Aps, Sonova Retail Denmark Aps Vis mere
CVR16753181
AdresseHans Edvard Teglers Vej 5, 1, 2920 Charlottenlund
BrancheDetailhandel med andre medicinske og ortopædiske artikler [477420]
Etableret01-01-1993 (32 år)
Første regnskabsperiode01-01-1993 til 30-04-1994
VirksomhedsformAnpartsselskab
Antal ansatte186 (årsværk:174)
ReklamebeskyttelseNej
RevisorEy Godkendt Revisionspartnerselskab siden 30-06-2020
Regnskabsperiode01-04 til 31-03
Selskabskapital480.000 DKK
460.000 DKK (20-02-2023 - 17-03-2024)
440.000 DKK (28-03-2022 - 19-02-2023)
420.000 DKK (19-03-2020 - 27-03-2022)
400.000 DKK (10-02-2020 - 18-03-2020)
380.000 DKK (15-03-2019 - 09-02-2020)
Vedtægter seneste18-03-2024

Medlem af brancherne

Formål

Selskabets formål er handel med, behandling af patienter med og undervisning vedrørende høreapparater, investering i andre selskaber, der driver virksomhed hermed samt anden i forbindelse hermed stående virksomhed.

Regnskab

 202420232022
Valuta/enhed000' DKK000' DKK000' DKK
Omsætning
223.189
+12%
200.089
+14%
174.970
-6%
Bruttofortjeneste
88.896
+41%
62.865
+11%
56.595
-36%
Årets resultat
-6.563
-
-29.724
-
-26.441
-
Egenkapital
47.201
+215%
14.964
+2%
14.688
-58%
Balance
98.774
+16%
85.464
0%
85.676
-19%

Ledelsesberetning sammendrag

Ledelsesberetning
Management's review
Beskrivelse af virksomhedens væsentligste aktiviteter
The principal activities of the company
The Company's main activity is sales of hearing aid and related services.
Beskrivelse af udviklingen i virksomhedens aktiviteter og økonomiske forhold
Development in activities and financial matters
The revenue for the year is DKK 223,189 thousand against DKK 200,089 thousand last year. The results after tax are DKK -6,563 thousand against DKK -29,724 thousand last year. Although strong growth vs prior year, the negative result is seen as not satisfying comparing to expectations of a net result in the range of DKK -5,000-0 thousand. The negative result for the year is solely driven by less sales than budgeted for and is primarily driven by a challenging Q1 and to a less degree the combination of inflation and increased competition.
In 2023/24 the Company has received final settlement of DKK 2,040 thousand in Government grants related to compensation for the impact of Covid-19 in 2020/21.
In March 2024 the shareholder of the company made a share capital increase of 1 share by cash contribution, a total of DKK 38,800 thousand incl premium.
The private market for Hearing aid products and -service has grown, but entry of new market players and regained growth plans from main competition, including the public sector and local Ear, Nose & Throat Doctors, has increased competition. However during the fiscal year the company’s market share has increased again and are for the full year satisfying with a significant growth in total market shares.
Strategy
Sonova Audiological Care Denmark ApS offers a complete range of digital hearing instruments, wireless FM systems and personal hearing protection.
The development and manufacture of hearing instruments take place primarily in Stäfä, (Switzerland) where the Sonova Group has its headquarters and in Kitchener (Ontario, Canada), whereas wireless communication systems are manufactured in Murten (Switzerland).
Product innovation, customer focus and cost management are the three pillars in the strategy.
Omtale af betydningsfulde hændelser, som er indtruffet efter regnskabsårets afslutning
Events after the balance sheet date
No events materially affecting the assessment of the Annual Report have occurred after the balance sheet date.
Beskrivelse af virksomhedens forventede udvikling
The expected development
In 2024/25 the Company will continue to growth and continue to develop and further strengthen its business model leading to continued growth. The Company’s financial result for 2024/25 is expected to increase due to continued, stable growth in the market leading to market share gains. Additional Go-to-market strategies and efficiency gains in existing clinic portfolio drives improved results. On this basis, revenue in the range of DKK 225,000 – 250,000 thousand and a result in the range of DKK 0 – 5,000 thousand are expected for 2024/25. Management expects to service more customers and increase efficiency in the shops further with development of the business model.
For 2024/25 and subsequent years, Management expects that hearing aid prices in Denmark will remain under pressure. This will require a continued focus on costs and efficiencies and competitive products and services. Management is confident that the Company is well positioned to maintain and further develop the market leader position in the Danish market. The Company expects a continuing positive development in the coming years.
Generalforsamlingsdato: 28-06-2024

Kort